Does Rallies show 13F holders for ALHC?

Yes. Rallies tracks hedge fund and 13F ownership data for ALHC, including fund names, share counts, latest tracked quarter, and position changes when available.

Is ALHC research on Rallies investment advice?

No. Rallies provides research, data, and educational context for ALHC. It does not provide personalized investment advice.

ALHC (Alignment Healthcare, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings

Alignment Healthcare, Inc. Common Stock (ALHC) is a publicly traded Healthcare sector company. As of May 21, 2026, ALHC trades at $17.31 with a market cap of $3.37B and a P/E ratio of 0.00. ALHC moved +1.80% today. Year to date, ALHC is -20.67%; over the trailing twelve months it is +6.25%. Its 52-week range spans $9.15 to $23.87. Analyst consensus is strong buy with an average price target of $24.50. Rallies surfaces ALHC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns ALHC stock?

Hedge funds tracked by Rallies that own ALHC include Orbimed Advisors, Panagora Asset, Mangrove Partners, Centerbook Partners, and Pinebridge Investments. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Alignment Healthcare, Inc. Common Stock.

ALHC Key Metrics

Key financial metrics for ALHC
Metric	Value
Price	$17.31
Market Cap	$3.37B
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	0.00%
52-Week High	$23.87
52-Week Low	$9.15
Volume	1.09K
Avg Volume	0
Revenue (TTM)	$3.95B
Net Income	$-978.00K
Gross Margin	0.00%

Top Hedge Funds Holding ALHC

Orbimed Advisors holds 791.00K shares of ALHC, changed +0.00% as of Mar 31, 2026.
Panagora Asset holds 295.59K shares of ALHC, changed +0.00% as of Mar 31, 2026.
Mangrove Partners holds 14.28K shares of ALHC, changed +0.00% as of Sep 30, 2024.
Centerbook Partners holds 10.98K shares of ALHC, changed -55.71% as of Mar 31, 2026.
Pinebridge Investments holds 1.96K shares of ALHC, changed +0.00% as of Jun 30, 2023.

Latest ALHC News

Alignment Health Plan Earns 2026 Excellence Award, In Top 1.6% of MAPD Plans — May 14, 2026
Alignment Healthcare Elevates CEO to Chairman Role and Adds Three Senior Executives — May 12, 2026
Alignment Healthcare Raises 2026 Guidance After 33% Q1 Revenue Gain — May 1, 2026
Analysts Forecast Q1 Revenue of $1.22B, See 15.7% Upside on Alignment Healthcare — Apr 29, 2026
Insiders Sell 95,639 Shares for $1.7M; Hudson Bay Takes 262,500-Share Stake — Mar 22, 2026

Recent ALHC Insider Trades

KAO JOHN E sold 280.89K (~$4.73M) on May 11, 2026.
KAO JOHN E sold 17.11K (~$299.97K) on May 11, 2026.
Maroney Dawn Christine sold 30.00K (~$626.20K) on Apr 15, 2026.

ALHC Analyst Consensus

9 analysts cover ALHC: 0 strong buy, 7 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $24.50.

Common questions about ALHC

Who owns ALHC stock?: Hedge funds tracked by Rallies that own ALHC include Orbimed Advisors, Panagora Asset, Mangrove Partners, Centerbook Partners, and Pinebridge Investments. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Alignment Healthcare, Inc. Common Stock.
Does Rallies show 13F holders for ALHC?: Yes. Rallies tracks hedge fund and 13F ownership data for ALHC, including fund names, share counts, latest tracked quarter, and position changes when available.
Is ALHC research on Rallies investment advice?: No. Rallies provides research, data, and educational context for ALHC. It does not provide personalized investment advice.